arrow
L

Liyuan Ge

Peking University Third Hospital
H指数:15
被引数:794

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASO Author Reflections: Risk Stratification by Model Shows the Efficacy of ICIs but Not a Benefit of TKI in Postoperative Recurrence or Metastasis of Non-Metastatic ccRCC

ASO作者反思:模型风险分层显示ICI在非转移性ccRCC术后复发或转移中的有效性,但未显示TKI的益处

2026-09-290
PRE
ASO Visual Abstract: A Pathology-Based Model for Postoperative Recurrence or Metastasis Prediction and Adjuvant Immunotherapy Implications of Clear-Cell Renal Cell Carcinoma: A Multicenter, Retrospective Study

ASO视觉摘要:基于病理学的透明细胞肾细胞癌术后复发或转移预测模型及辅助免疫治疗意义:一项多中心回顾性研究

2026-08-210
PRE
A Pathology-Based Model for Postoperative Recurrence or Metastasis Prediction and Adjuvant Immunotherapy Implications of Clear-Cell Renal Cell Carcinoma: A Multicenter, Retrospective Study

基于病理学的透明细胞肾细胞癌术后复发或转移预测及辅助免疫治疗意义的模型:一项多中心、回顾性研究

2026-08-080
PRE